XML 29 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Income Statement - CAD ($)
$ in Millions
 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Profit or loss [abstract]    
Revenue $ 4,707.9 $ 4,282.8
Cost of sales 3,407.8 3,128.3
Gross profit 1,300.1 1,154.5
Research and development expenses 123.2 149.8
Selling, general and administrative expenses 565.4 535.0
Other (gains) and losses (13.3) 27.9
Share of after-tax profit of equity accounted investees (88.3) (72.2)
Restructuring, integration and acquisition costs 56.5 131.4
Impairment of goodwill 0.0 568.0
Gain on remeasurement of previously held equity interest (72.6) 0.0
Operating income (loss) 729.2 (185.4)
Finance expense – net 215.5 205.0
Earnings (loss) before income taxes 513.7 (390.4)
Income tax expense (recovery) 98.7 (72.8)
Net income (loss) from continuing operations 415.0 (317.6)
Net income from discontinued operations 0.0 21.3
Net income (loss) 415.0 (296.3)
Attributable to:    
Equity holders of the Company 405.3 (304.0)
Non-controlling interests $ 9.7 $ 7.7
Earnings (loss) per share attributable to equity holders of the Company    
Basic – continuing operations (in Canadian dollars per share) $ 1.27 $ (1.02)
Diluted - continuing operations (in Canadian dollars per share) 1.27 (1.02)
Basic - discontinued operations (in Canadian dollars per share) 0 0.07
Diluted - discontinued operations (in Canadian dollars per share) $ 0 $ 0.07